Stocktoria

Teva Pharmaceutical Industries Limited TEVA.TA

IL · Tel Aviv Stock Exchange · XTAE · stock · Healthcare · website

Teva Pharmaceutical Industries Limited statistics & valuation

Market cap$124.7B
P / E88.4×
P / S7.2×
P / B15.8×
P / FCF108.6×
Net margin8.2%
Return on equity17.8%
FCF margin6.7%
Net debt$13.5B
Enterprise value$138.2B
Earnings yield EBIT/EV2.9%
Return on capital14.5%
Graham number -99.9%$13.59

Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($13.59); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-16.40% -3.50% -9.90% 8.20% 2022202320242025
Gross margin (%)
46.70% 48.20% 48.70% 51.80% 2022202320242025
Operating margin (%)
18.00% 20.20% 20.30% 22.90% 2022202320242025
Return on equity (%)
-31.30% -7.40% -30.50% 17.80% 2022202320242025
Shares outstanding
1.17B 1.17B 1.17B 1.17B 2022202320242025
Net debt ($)
$18.76B $16.93B $14.78B $13.54B 2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-5.60% -1.30% -4.20% 3.50% 2022202320242025
Free cash flow margin (%)
7.00% 5.30% 4.50% 6.70% 2022202320242025
Debt / equity (×)
2.76× 2.68× 3.36× 2.16× 2022202320242025
EPS ($)
-$2.12 -$0.50 -$1.45 $1.21 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Gross margin51.8%48.7%48.2%46.7%
Operating margin22.9%20.3%20.2%18.0%
Net margin8.2%-9.9%-3.5%-16.4%
FCF margin6.7%4.5%5.3%7.0%
Return on assets3.5%-4.2%-1.3%-5.6%
Return on equity17.8%-30.5%-7.4%-31.3%
Debt / equity1.89×2.98×2.42×2.45×
Current ratio1.040.981.021.05

Computed from company filings · IL · as of 2025-12-31. Figures in USD. Facts plus Stocktoria's own computed scores — not investment advice.